BJ
DRNA

BlackRock Japan’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

BlackRock Japan’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,498
Closed -$34K – 1341
2014
Q2 		$34K Hold
1,498
– – ﹤0.01% 1091
2014
Q1 		$42K Buy
+1,498
New +$55.7K ﹤0.01% 1184

Other funds holding DRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock Japan's DRNA Position: Q3 2014 in Review

BlackRock Japan sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2014, closing a stake of 1,498 shares — an estimated $34K sold.

BlackRock Japan first reported a position in DRNA in Q1 2014 and held it in 2 quarters. The position peaked at $42K in Q1 2014. 40 funds tracked by Wall St. Rank hold DRNA as of Q3 2014.

  • BlackRock Japan reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
  • BlackRock Japan sold 1,498 Dicerna Pharmaceuticals, Inc. shares in Q3 2014, an estimated $34K.
  • BlackRock Japan first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • BlackRock Japan's Dicerna Pharmaceuticals, Inc. position peaked at $42K in Q1 2014.
  • 40 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2014.

Based on BlackRock Japan's 13F filing for Q3 2014, filed 29 Oct 2014.